These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29274375)

  • 1. Meta-analysis: Risk of dry mouth with second generation antidepressants.
    Cappetta K; Beyer C; Johnson JA; Bloch MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):282-293. PubMed ID: 29274375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis: Second generation antidepressants and headache.
    Telang S; Walton C; Olten B; Bloch MH
    J Affect Disord; 2018 Aug; 236():60-68. PubMed ID: 29715610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.
    Beyer C; Cappetta K; Johnson JA; Bloch MH
    Depress Anxiety; 2017 Dec; 34(12):1134-1146. PubMed ID: 28881483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
    JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-analysis.
    Mills JA; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2020 Nov; 59(11):1240-1251. PubMed ID: 31682918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: questionable benefit and considerations for frailty.
    Mallery L; MacLeod T; Allen M; McLean-Veysey P; Rodney-Cail N; Bezanson E; Steeves B; LeBlanc C; Moorhouse P
    BMC Geriatr; 2019 Nov; 19(1):306. PubMed ID: 31718566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and safety: essentials in antidepressant pharmacotherapy.
    Lader MH
    J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
    McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN
    Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-Analysis of Placebo Response in Adult Antidepressant Trials.
    Li F; Nasir M; Olten B; Bloch MH
    CNS Drugs; 2019 Oct; 33(10):971-980. PubMed ID: 31573058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for the management of dry mouth: non-pharmacological interventions.
    Furness S; Bryan G; McMillan R; Worthington HV
    Cochrane Database Syst Rev; 2013 Aug; (8):CD009603. PubMed ID: 23996155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin and norepinephrine reuptake inhibitors association with dry mouth in a hospital population.
    Katz J; Brooks S
    Quintessence Int; 2023 Feb; 54(2):150-154. PubMed ID: 36625886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence.
    Nelson JC; Delucchi K; Schneider LS
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):558-67. PubMed ID: 18591576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of placebo group dropout in adult antidepressant trials.
    Li F; Nasir M; Olten B; Bloch MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 98():109777. PubMed ID: 31697973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders: A Report of 2 Meta-analyses.
    Roest AM; de Jonge P; Williams CD; de Vries YA; Schoevers RA; Turner EH
    JAMA Psychiatry; 2015 May; 72(5):500-10. PubMed ID: 25806940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of depression--newer pharmacotherapies.
    Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
    Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.
    Carpenter DJ; Fong R; Kraus JE; Davies JT; Moore C; Thase ME
    J Clin Psychiatry; 2011 Nov; 72(11):1503-14. PubMed ID: 21367354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Second-Generation Antidepressants in Reducing the Risk of Dementia in Elderly Nursing Home Residents with Depression.
    Bali V; Holmes HM; Johnson ML; Chen H; Fleming ML; Aparasu RR
    Pharmacotherapy; 2016 Jan; 36(1):38-48. PubMed ID: 26748455
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.